Literature DB >> 32765164

Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age.

Marta Velasco Rodríguez-Belvís1, Javier Francisco Viada Bris1, Carmen Plata Fernández2, Alberto García-Salido3, Julia Asensio Antón2, Gloria Domínguez Ortega1, Rosa Ana Muñoz Codoceo1.   

Abstract

BACKGROUND/
OBJECTIVES: The paediatric reference range of fecal calprotectin (FC) has not been decisively established and previous studies show a wide within-age variability, suggesting that other factors like anthropometric data or type of feeding can influence FC. Our aims were to establish the normal levels of FC in healthy children grouped by age and analyze whether sex, gestational age, birth weight, type of delivery, type of feeding, or anthropometric data influence FC values.
METHODS: This multicentre, cross-sectional, and observational study enrolled healthy donors under 18 years of age who attended their Primary Health Care Centre for their routine Healthy Child Program visits. The exclusion criteria were: (i) immunodeficiency, (ii) autoimmune or (iii) gastrointestinal disease; (iv) medication usage; (v) gastrointestinal symptoms; or (vi) positive finding in the microbiological study.
RESULTS: We enrolled 395 subjects, mean age was 4.2 years (range 3 days to 16.9 years), and 204 were male. The median FC was 77.0 mcg/g (interquartile range 246). A negative correlation between age and FC was observed (Spearman's rho = -0.603, P<0.01), and none of the other factors analyzed were found to influence FC levels.
CONCLUSIONS: Normal FC values in healthy children (particularly in infants) are higher than those considered to be altered in adults and show a negative correlation with age. It is necessary to reconsider the upper limits of FC levels for paediatric patients according to age, with further studies required to determine other factors that influence FC during infancy.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Children; Fecal calprotectin; Healthy

Year:  2019        PMID: 32765164      PMCID: PMC7395315          DOI: 10.1093/pch/pxz070

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  41 in total

1.  High faecal calprotectin levels in healthy, exclusively breast-fed infants.

Authors:  Francesco Savino; Emanuele Castagno; Roberto Calabrese; Serena Viola; Roberto Oggero; Roberto Miniero
Journal:  Neonatology       Date:  2009-11-04       Impact factor: 4.035

2.  Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.

Authors:  E Olafsdottir; L Aksnes; G Fluge; A Berstad
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

3.  Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.

Authors:  Els Van de Vijver; Andrea Bertilde Schreuder; Wybrich Riemke Cnossen; Anna Caecilia Muller Kobold; Patrick Ferry van Rheenen
Journal:  Arch Dis Child       Date:  2012-09-27       Impact factor: 3.791

Review 4.  Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.

Authors:  Anthony K Akobeng
Journal:  Acta Paediatr       Date:  2018-05-21       Impact factor: 2.299

5.  Fecal Calprotectin and Eosinophil-derived Neurotoxin in Healthy Children Between 0 and 12 Years.

Authors:  María Roca; Ana Rodriguez Varela; Ester Donat; Francisco Cano; David Hervas; Ana Armisen; Maria J Vaya; Anders Sjölander; Carmen Ribes-Koninckx
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

6.  Paediatric reference ranges for faecal calprotectin: a UK study.

Authors:  Fiona Davidson; Robert J Lock
Journal:  Ann Clin Biochem       Date:  2016-09-30       Impact factor: 2.057

7.  High faecal calprotectin concentrations in newborn infants.

Authors:  F Campeotto; M J Butel; N Kalach; S Derrieux; C Aubert-Jacquin; L Barbot; C Francoual; C Dupont; N Kapel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

8.  Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.

Authors:  Gea A Holtman; Yvonne Lisman-van Leeuwen; Andrew S Day; Ulrika L Fagerberg; Paul Henderson; Stevan T Leach; Gøri Perminow; David Mack; Patrick F van Rheenen; Els van de Vijver; David C Wilson; Johannes B Reitsma; Marjolein Y Berger
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 26.796

Review 9.  Innate Immunity and Breast Milk.

Authors:  Nicole Theresa Cacho; Robert M Lawrence
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

10.  Fecal Calprotectin in Healthy Children Aged 1-4 Years.

Authors:  Qingling Zhu; Feng Li; Junli Wang; Lixiao Shen; Xiaoyang Sheng
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

View more
  4 in total

1.  Fecal calprotectin in healthy children aged 4-16 years.

Authors:  María Roca; Ana Rodriguez Varela; Eva Carvajal; Ester Donat; Francisco Cano; Ana Armisen; Maria Jose Vaya; Helena Ekoff; David Hervas; Niclas Rydell; Carmen Ribes-Koninckx
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

Review 2.  Faecal Microbiota in Infants and Young Children with Functional Gastrointestinal Disorders: A Systematic Review.

Authors:  Denise Hofman; Urszula Kudla; Mohamad Miqdady; Thi Viet Ha Nguyen; Sofía Morán-Ramos; Yvan Vandenplas
Journal:  Nutrients       Date:  2022-02-25       Impact factor: 5.717

3.  Fecal calprotectin levels in pediatric cow's milk protein allergy.

Authors:  Dominika Lendvai-Emmert; Vanessza Emmert; Alexandra Makai; Katalin Fusz; Viktória Prémusz; Kata Eklics; Patrícia Sarlós; Péter Tóth; Krisztina Amrein; Gergely Tóth
Journal:  Front Pediatr       Date:  2022-08-09       Impact factor: 3.569

Review 4.  Calprotectin in inflammatory bowel disease.

Authors:  Fatemeh Khaki-Khatibi; Durdi Qujeq; Mehrdad Kashifard; Soheila Moein; Mahmood Maniati; Mostafa Vaghari-Tabari
Journal:  Clin Chim Acta       Date:  2020-08-18       Impact factor: 3.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.